Home › Funds › Citigroup Inc › BLTE
Citigroup Inc position in BLTE
BELITE BIO INC · Health Care
Latest position (Q2 2026)47 sh
Reported value held$7.24K
Portfolio Weight0.00%
First reportedQ1 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3 | $199 | New |
| Q3 2025 | 4.01K | $296.74K | New |
| Q4 2025 | 2.14K | $341.83K | Reduce |
| Q1 2026 | 1 | $159 | Reduce |
| Q2 2026 | 47 | $7.24K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BLTE
- Millennium Management 494.56K sh · $76.16M · Q2 2026
- Maverick Capital 396.31K sh · $61.03M · Q2 2026
- Morgan Stanley 235.07K sh · $36.20M · Q2 2026
- UBS Group AG 224.99K sh · $34.64M · Q2 2026
- Citadel Advisors 186.17K sh · $28.67M · Q2 2026
- Goldman Sachs Group 166.19K sh · $25.59M · Q2 2026
- Bank of America Corp 124.78K sh · $19.21M · Q2 2026
- Renaissance Technologies 55.76K sh · $8.59M · Q2 2026
- Point72 Asset Management 51.19K sh · $7.88M · Q2 2026
- Two Sigma Investments 38.10K sh · $5.87M · Q2 2026
- JPMorgan Chase & Co 33.18K sh · $5.13M · Q2 2026
- Geode Capital Management 22.64K sh · $3.49M · Q2 2026